The North America clinical trials market was valued at USD 35.31 billion in 2023 and is projected to grow at a compound annual growth rate (CAGR) of 6.0% between 2024 and 2032, reaching USD 60.16 billion by 2032. This significant growth is driven by various factors including advancements in medical research, increasing healthcare investments, and growing demand for innovative therapies. The...